EPIDEMIOLOGIChESKIE I MOLEKULYaRNO-GENETIChESKIE OSOBENNOSTI GENITAL'NOY PAPILLOMAVIRUSNOY INFEKTsII U ZhENShchIN, PROZhIVAYuShchIKh V RESPUBLIKE BELARUS'

G I Vergeychik , Zh A Stribuk , V F Eremin

Russian Journal of Oncology ›› 2010, Vol. 15 ›› Issue (6) : 15 -19.

PDF
Russian Journal of Oncology ›› 2010, Vol. 15 ›› Issue (6) : 15 -19. DOI: 10.17816/onco39727
Articles
other

EPIDEMIOLOGIChESKIE I MOLEKULYaRNO-GENETIChESKIE OSOBENNOSTI GENITAL'NOY PAPILLOMAVIRUSNOY INFEKTsII U ZhENShchIN, PROZhIVAYuShchIKh V RESPUBLIKE BELARUS'

Author information +
History +
PDF

Abstract

The paper presents the results of an epidemiological study, which have determined the territorial features of the prevalence of oncogenic human papillomaviruses (HPV) responsible for the development of precancer and cancer of the cervix uteri in women living in the Republic of Belarus. The got basic knowledge about the molecular epidemiology of HPV infection will enable one to determine new landmarks for the treatment and follow-up of patients, by taking into account detected HPV genotypes and their carcinogenic potential, and to assess the expediency and potential outlook of immunization with first-generation vaccines at the population level.

Keywords

papillomavirus infection / epidemiology / dominant oncogenic HPV genotypes

Cite this article

Download citation ▾
G I Vergeychik, Zh A Stribuk, V F Eremin. EPIDEMIOLOGIChESKIE I MOLEKULYaRNO-GENETIChESKIE OSOBENNOSTI GENITAL'NOY PAPILLOMAVIRUSNOY INFEKTsII U ZhENShchIN, PROZhIVAYuShchIKh V RESPUBLIKE BELARUS'. Russian Journal of Oncology, 2010, 15(6): 15-19 DOI:10.17816/onco39727

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Arbin M., Sasieni P., Mejer C. J. et al. // Vaccine. - 2006. - Vol. 24. - Suppl. 3. - P. S78-S89.

[2]

Cuzick J., Arbyn M., Sankaranarayanan R. et al. // Vaccine. - 2008. - Vol. 26. - Suppl. 10. - P. S29-S41.

[3]

Harper D. M., Franco E. L., Wheeler C. M. et al. // Lancet. - 2006. - Vol. 367. - P. 1247-1255.

[4]

Inoue M., Sakaguchi J., Sasagawa T., Tango M. // Int. J Gynecol. Cancer. - 2006. - Vol. 16, N 3. - P. 1007-1013.

[5]

Koutsky L. A., Harper D. M. // Vaccine. - 2006. - Vol. 24. - Suppl. 3. - P. S114-S121.

[6]

Munoz N., Bosch F. X., Castellsaguй X. et al. // Int. J. Cancer. - 2004. - Vol. 111, N 2. - P. 278-285.

[7]

Parkin D. M. // Int. J. Cancer. - 2006. - Vol. 118, N 12. - P. 3030-3044.

[8]

Parkin D. M., Bray F. // Vaccine. - 2006. - Vol. 24. - Suppl. 3. - P. S11-S25.

[9]

Pina-Sanchez P., Hernandez-Hernandez D. M., Lopez-Romero R. et al. // Int. J. Gynecol. Cancer. - 2006. - Vol. 16, N 3. - P. 1041-1047.

[10]

Smith J. S., Lindsay L., Hoots B. et al. // Int. J. Cancer. - 2007. - Vol. 121, N 3. - P. 621-632.

[11]

Stevens M. P., Tabrizi S. N., Quinn M. A., Garland S. M. // Int. J. Gynecol. Cancer. - 2006. - Vol. 16, N 3. - P. 1017-1024.

[12]

Tawfik El-Mansi M., Cuschien K. S., Morris R. G., Willams A. R. // Int. J. Gynecol. Cancer. - 2006. - Vol. 16, N 3. - P. 1025-1031.

[13]

Wieland U., Pfister H. // Human Papilloma Virus: A Clinical Atlas / Eds Gross, Barasso. - 1997. - P. 1-18.

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

130

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/